Please login to the form below

Not currently logged in
Email:
Password:

business model

This page shows the latest business model news and features for those working in and with pharma, biotech and healthcare.

BioNTech bolsters COVID-19 vaccine capacity with Novartis deal

BioNTech bolsters COVID-19 vaccine capacity with Novartis deal

From a strategic standpoint, the new site will bolster our vertically integrated business model with in-house manufacturing capabilities for mRNA manufacturing as well as vaccine formulation,” he added.

Latest news

  • Trust – years to build, seconds to break and forever to repair Trust – years to build, seconds to break and forever to repair

    These are being viewed by the public at record levels. Having an understanding of the complexity of drug development is one of the fundamentals in establishing trust in how our business ... model works and in supporting discussions around IP, access,

  • Awesome abstraction Awesome abstraction

    Business development deals and commercial operating models show the power of Generalised Darwinism. ... So, there is no single model. Instead, a little like the business development example, we are beginning to see a speciation in commercial models

  • Antibiotic biotech Melinta files for bankruptcy Antibiotic biotech Melinta files for bankruptcy

    Worries over antibiotic business model continue to mount. Antibiotic maker Melinta has filed for bankruptcy, as fears continue to mount over so-called ‘superbugs’ that are resistant to currently approved antibiotics. ... The financial collapse of

  • Sandoz expands into Japan with €400m Aspen deal Sandoz expands into Japan with €400m Aspen deal

    The agreement will see Sandoz acquire the entirety of Aspen Global Incorporated’s (AGI) Japanese business division, which is a wholly owned subsidiary of Aspen Pharmacare Holdings Limited. ... This transaction complements our stated strategic intent to

  • Sumitomo Dainippon goes big on biotech with $3bn Roivant deal Sumitomo Dainippon goes big on biotech with $3bn Roivant deal

    Roivant’s business model is unique in that it focuses on acquiring drug candidates that have been discarded by other companies for commercial reasons, rather than a fundamental issue with the

More from news
Approximately 1 fully matching, plus 235 partially matching documents found.

Latest Intelligence

  • Driving the innovation engine Driving the innovation engine

    Routine’ innovation builds on a company’s existing technological competences and fits with its existing business model and customer base. ... The boundary is that it’s limited to the stakeholders – including, for instance, the venture capital

  • Darwinian leadership in the life sciences industry Darwinian leadership in the life sciences industry

    There is hardly an idea or a human activity that has not be held up by some author or other as the model for leadership in business. ... Even compared to other capital-intensive businesses, pharma and medtech is an exceptionally risky business.

  • Vertex: a vision of treating all CF patients worldwide draws closer Vertex: a vision of treating all CF patients worldwide draws closer

    This certainly looks like a very healthy business, but as Jeff Leiden was at pains to point out to the recent health select committee hearing in London, the company has made ... However, as in other disease areas, it threatens to upend the biopharma

  • The Orkambi blame game The Orkambi blame game

    were ‘freeloading’ while high US prices provide the incentive for the industry’s R&D-based business model. ... Vertex, at £850m a year, would go out of business in three to five years.

  • Lonely planet: why there is dwindling value in pharma travelling alone Lonely planet: why there is dwindling value in pharma travelling alone

    To develop sustainable business models that establish value ‘beyond the pill’, collaboration is the best way forward. ... Pharma has recognised the need to change its traditional business model and explore more collaborative ways of working.

More from intelligence
Approximately 0 fully matching, plus 45 partially matching documents found.

Latest appointments

  • Neurocentrx appoints two members to the board Neurocentrx appoints two members to the board

    Brooksby brings experience in business and growth strategy across the healthcare sector having held senior global positions at Pfizer, Sanofi and Wellcome - now GSK. ... Brooksby said: “My focus is to accelerate the business model and drive commercial

  • Rainer Boehm and Hervé Hoppenot join Cellectics board Rainer Boehm and Hervé Hoppenot join Cellectics board

    Boehm spent 29 years serving Novartis working in various senior management, marketing, sales, and medical affairs roles, and his expertise spans from leadership and development to business model solutions. ... oncology and head of the US oncology

  • Novocure’s chief commercial officer to step down Novocure’s chief commercial officer to step down

    During his tenure, Peter developed our commercial business model, launched the Optune brand and drove eight consecutive quarters of active patient and revenue growth after the presentation of our EF-14

  • Galenica Group strengthens management team Galenica Group strengthens management team

    We opted for these variant because of the excellent knowledge Stefan Schulze brings to further developing the business model of Vifor Pharma.”. ... Santé. Burkhard joined the Galenica Group in 1996 as corporate controller of Galenica, taking

  • Moderna Therapeutics appoints chief business officer Moderna Therapeutics appoints chief business officer

    Saqib Islam brings experience from Alexion Pharmaceuticals. Cambridge, Massachusetts-based Moderna Therapeutics has appointed Saqib Islam as its new chief business officer from 9 May. ... Islam said: “Already a clinical stage company, Moderna has

More from appointments
Approximately 0 fully matching, plus 16 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 23 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics